Skip to content

KRAKacquisition KRAQ Proceeds From Issuance Initial Public Offering

Proceeds From Issuance Initial Public Offering at other companies

Silvaco Group, Inc. logo
Silvaco Group, Inc.SVCO
$0-100%
CeriBell, Inc. logo
CeriBell, Inc.CBLL
$0-100%
Lightpath Technologies logo
Lightpath TechnologiesLPTH
$8.05M
Diversified Energy
 logo
Diversified Energy DEC
$0-100%
Phathom Pharmaceuticals, Inc. logo
Phathom Pharmaceuticals, Inc.PHAT
$121.97M
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$1.88M

Other financials

Income statement

See full
Operating income-$11.0M
Net income-$8.9M
EPS (diluted)-$0.01

Balance sheet

See full
Cash & equivalents$824.6K
Total debt$77.4K
Total equity-$19.9M
Total assets$348.0M

Cash flow

See full
Operating cash flow-$669.9K

Valuation

See full
Market cap$430.77M+0.9%
Enterprise value$430.02M

Returns & leverage

See full
Debt / equity-0×
Current ratio7.7×

Where this comes from

Reported directly by KRAKacquisition in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceInitialPublicOffering.

The official record: KRAKacquisition ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about KRAKacquisition 's proceeds from issuance initial public offering.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KRAKacquisition 's proceeds from issuance initial public offering?
KRAKacquisition (KRAQ) reported proceeds from issuance initial public offering of $342.42M in Q1 2026.